Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Intranasal Drug Delivery Devices Market Variables and Scope 

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Intranasal Drug Delivery Devices Market

5.1. Covid-19: Intranasal Drug Delivery Devices Industry Impact
5.2. Intranasal Drug Delivery Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Intranasal Drug Delivery Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19 
5.3.2. Proposal for Intranasal Drug Delivery Devices Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Intranasal Drug Delivery Devices Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. High prevalence of cardiovascular diseases
6.1.1.2. Patent expiration of popular drugs, increased cases of cancer and diabetes
6.1.2. Market Restraints
6.1.2.1. Complications Associated with the Overuse
6.1.3. Market Opportunities
6.1.3.1. Growing adoption of self-administration practices
6.1.3.2. Technological advancements

Chapter 7. Global Intranasal Drug Delivery Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Intranasal Drug Delivery Devices Market Revenue by Market Players
7.1.1.2. Intranasal Drug Delivery Devices Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, System Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Intranasal Drug Delivery Devices Market, By System

8.1. Intranasal Drug Delivery Devices Market, by System, 2023-2032
8.1.1. Metered Dose
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Multi-Dose Systems
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Unit-Dose Systems
8.1.3.1. Market Revenue and Forecast (2021-2032)

Chapter 9. Global Intranasal Drug Delivery Devices Market, By Container

9.1. Intranasal Drug Delivery Devices Market, by Container, 2023-2032
9.1.1. Non-Pressurized Containers
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Pressurized Containers
9.1.2.1. Market Revenue and Forecast (2021-2032)

Chapter 10. Global Intranasal Drug Delivery Devices Market, By Application

10.1. Intranasal Drug Delivery Devices Market, by Application, 2023-2032
10.1.1. Chronic Obstructive Pulmonary Disease (COPD)
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Rhinitis
10.1.2.1. Market Revenue and Forecast (2021-2032)
10.1.3. Cystic Fibrosis
10.1.3.1. Market Revenue and Forecast (2021-2032)
10.1.4. Nasal Congestion
10.1.4.1. Market Revenue and Forecast (2021-2032)
10.1.5. Asthma
10.1.5.1. Market Revenue and Forecast (2021-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2021-2032)

Chapter 11. Global Intranasal Drug Delivery Devices Market, By End User

11.1. Intranasal Drug Delivery Devices Market, by End User, 2023-2032
11.1.1. Ambulatory Surgical Centers
11.1.1.1. Market Revenue and Forecast (2021-2032)
11.1.2. Clinics
11.1.2.1. Market Revenue and Forecast (2021-2032)
11.1.3. Hospitals
11.1.3.1. Market Revenue and Forecast (2021-2032)
11.1.4. Others
11.1.4.1. Market Revenue and Forecast (2021-2032)

Chapter 12. Global Intranasal Drug Delivery Devices Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by System(2021-2032)
12.1.2. Market Revenue Forecast by Container(2021-2032)
12.1.3. Market Revenue Forecast by Application(2021-2032)
12.1.4. Market Revenue Forecast by End User (2021-2032)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2032)
12.1.6. Canada 
12.1.6.1. Market Revenue Forecast (2021-2032)
12.2. Europe
12.2.1. Market Revenue Forecast by System (2021-2032)
12.2.2. Market Revenue Forecast by Container (2021-2032)
12.2.3. Market Revenue Forecast by Application (2021-2032)
12.2.4. Market Revenue Forecast by End User (2021-2032)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2032)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2032)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2032)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2032)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by System (2021-2032)
12.3.2. Market Revenue Forecast by Container (2021-2032)
12.3.3. Market Revenue Forecast by Application (2021-2032)
12.3.4. Market Revenue Forecast by End User (2021-2032)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2032)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2032)
12.3.7. Japan 
12.3.7.1. Market Revenue Forecast (2021-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2032)
12.4. LATAM
12.4.1. Market Revenue Forecast by System (2021-2032)
12.4.2. Market Revenue Forecast by Container (2021-2032)
12.4.3. Market Revenue Forecast by Application (2021-2032)
12.4.4. Market Revenue Forecast by End User (2021-2032)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2032)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2032)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by System (2021-2032)
12.5.2. Market Revenue Forecast by Container (2021-2032)
12.5.3. Market Revenue Forecast by Application (2021-2032)
12.5.4. Market Revenue Forecast by End User (2021-2032)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2032)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2032)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2032)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2032)

Chapter 13. Company Profiles

13.1. Johnson & Johnson, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2015-2020)
13.1.4. Recent Developments and Strategies
13.2. Aptar Pharma Group
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2015-2020)
13.2.4. Recent Developments and Strategies
13.3. GlaxoSmithKline Plc
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2015-2020)
13.3.4. Recent Developments and Strategies
13.4. Aegis Therapeutics LLC
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2015-2020)
13.4.4. Recent Developments and Strategies
13.5. H&T Presspart Manufacturing Ltd.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2015-2020)
13.5.4. Recent Developments and Strategies
13.6. AstraZeneca Plc
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2015-2020)
13.6.4. Recent Developments and Strategies
13.7. Becton, Dickinson and Company
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2015-2020)
13.7.4. Recent Developments and Strategies
13.8. Novartis AG
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2015-2020)
13.8.4. Recent Developments and Strategies
13.9. Teleflex Incorporated
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2015-2020)
13.9.4. Recent Developments and Strategies
13.10. Vectura Group Plc.
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2015-2020)
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms